Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange.

Fahad FaqihiAbdulrahman AlharthyZiad A MemishDemetrios J KutsogiannisPeter G BrindleyDimitrios Karakitsos

Published in: Clinical case reports (2020)

Peripheral neuropathies including Guillain-Barré syndrome may be linked to life-threatening COVID-19. Plasma exchange is a safe rescue therapy in severe COVID-19 with associated neurological manifestations and thromboinflammation.

Keyphrases

coronavirus disease
sars cov
early onset
respiratory syndrome coronavirus
stem cells
drug induced
bone marrow
blood brain barrier
brain injury
cell therapy